1. Home
  2. AURA vs CGBD Comparison

AURA vs CGBD Comparison

Compare AURA & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$6.02

Market Cap

797.5M

Sector

Health Care

ML Signal

HOLD

CGBD

Carlyle Secured Lending Inc.

HOLD

Current Price

$11.22

Market Cap

785.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AURA
CGBD
Founded
2007
2012
Country
United States
United States
Employees
N/A
2500
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
797.5M
785.1M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
AURA
CGBD
Price
$6.02
$11.22
Analyst Decision
Strong Buy
Hold
Analyst Count
5
8
Target Price
$20.00
$12.92
AVG Volume (30 Days)
616.2K
408.4K
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
14.42%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$3.74
Revenue Next Year
N/A
$1.80
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.73
$9.95
52 Week High
$9.54
$13.28

Technical Indicators

Market Signals
Indicator
AURA
CGBD
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
AURA
CGBD

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About CGBD Carlyle Secured Lending Inc.

Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.

Share on Social Networks: